NATURAL ALTERNATIVES INTERNATIONAL INC Accounts Payable
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) had Accounts Payable of $18.16 million as of 2026-03-31, per its 10-Q filed 2026-05-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-05-19
- 2026-03-31: Accounts Payable, Current $18.16M.
- 2025-12-31: Accounts Payable, Current $16.55M.
- 2025-09-30: Accounts Payable, Current $20.09M.
- 2025-06-30: Accounts Payable, Current $15.35M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-03-31 | $18.16M 10-Q · filed 2026-05-19 |
| 2025-12-31 | $16.55M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $20.09M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $15.35M 10-Q · filed 2026-05-19 |
| 2025-03-31 | $12.82M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $8.60M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $9.95M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $12.74M 10-K · filed 2025-09-23 |
| 2024-03-31 | $6.97M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $7.49M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $7.61M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $7.78M 10-K · filed 2024-09-27 |
| 2023-03-31 | $10.89M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $13.18M 10-Q · filed 2023-02-08 |
| 2022-09-30 | $17.66M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $16.18M 10-K · filed 2023-09-21 |
| 2022-03-31 | $17.84M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $10.14M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $13.01M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $11.89M 10-K · filed 2022-09-21 |
| 2021-03-31 | $15.30M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $12.38M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $17.77M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $12.51M 10-K · filed 2021-09-20 |
| 2020-03-31 | $10.67M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $5.44M 10-Q · filed 2020-02-11 |
| 2019-09-30 | $9.77M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $8.63M 10-K · filed 2020-09-21 |
| 2019-03-31 | $12.37M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $9.66M 10-Q · filed 2019-02-12 |
| 2018-09-30 | $10.06M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $9.65M 10-K · filed 2019-09-24 |
| 2018-03-31 | $13.80M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $12.18M 10-Q · filed 2018-02-13 |
| 2017-09-30 | $10.89M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $5.12M 10-K · filed 2018-09-19 |
| 2017-03-31 | $4.07M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $6.29M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $11.99M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $12.82M 10-K · filed 2017-09-18 |
| 2016-03-31 | $9.06M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $7.38M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $5.64M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $4.65M 10-K · filed 2016-09-19 |
| 2015-03-31 | $3.84M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $2.98M 10-Q · filed 2015-02-12 |
| 2014-09-30 | $4.18M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $6.42M 10-K · filed 2015-09-18 |
| 2014-03-31 | $4.66M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $4.13M 10-Q · filed 2014-02-12 |
| 2013-09-30 | $3.92M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $3.54M 10-K · filed 2014-09-25 |
| 2013-03-31 | $2.33M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $2.17M 10-Q · filed 2013-02-12 |
| 2012-09-30 | $2.12M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $3.92M 10-K · filed 2013-09-19 |
| 2012-03-31 | $2.21M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $3.33M 10-Q · filed 2012-02-13 |
| 2011-09-30 | $3.51M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $2.23M 10-K · filed 2012-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |